{
  "entity_id": "B-001022",
  "folder": "Life-Saving-Drugs-Program-Expert-Panel",
  "name": "Life Saving Drugs Program Expert Panel",
  "type": "Advisory Body",
  "jurisdiction": "Commonwealth",
  "portfolio": "Health, Disability and Ageing",
  "website": "https://www.health.gov.au/committees-and-groups/life-saving-drugs-program-expert-panel",
  "data_status": "partial",
  "completeness": {
    "has_strategy_brief": false,
    "has_strategy_structured": true,
    "has_vision": false,
    "has_kpi_targets": false,
    "has_kpi_results": false,
    "has_strategy_overview": true,
    "has_legislation_text": true,
    "has_legislation_structured": false,
    "has_global_initiatives_text": false,
    "has_ideas": true,
    "has_artifacts": true,
    "n_ideas": 12,
    "n_legislation": 0,
    "n_artifacts": 2,
    "n_kpi_targets": 0,
    "n_kpi_results": 0,
    "n_outcomes": 0,
    "verified_own_data": true
  },
  "strategy_profile": {
    "status": "needs_review",
    "confidence": "medium",
    "summary": "",
    "official_site_url": "https://www.health.gov.au/committees-and-groups/life-saving-drugs-program-expert-panel",
    "source_documents": [
      {
        "type": "strategie",
        "title": "Standard for AI transparency statements",
        "url": "https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf",
        "period": "2024",
        "confidence": "medium"
      }
    ],
    "purpose": null,
    "vision": null,
    "strategic_priorities": [],
    "values": [],
    "outcomes": [],
    "performance_measures": [],
    "document_alignment_terms": {
      "must_support": [],
      "watch_terms": [],
      "avoid_claiming_without_evidence": []
    },
    "review_note": "Structured strategy exists but is incomplete."
  },
  "strategy_brief_md": null,
  "strategy_overview_evidence_md": null,
  "internal_strategy_evidence_md": "# Life Saving Drugs Program Expert Panel - Strategy, Performance, and Operating Profile\n\n**Generated at**: 2026-05-09T22:18:45.143065+00:00\n**Entity ID**: B-001022\n**Entity type**: Advisory Body\n**Jurisdiction**: Commonwealth\n**Portfolio**: Health, Disability and Ageing\n**Website**: https://www.health.gov.au/committees-and-groups/life-saving-drugs-program-expert-panel\n\n> Draft generated from scraped source material. Treat this as an evidence pack for editorial review, not a final judgement.\n\n## Source Coverage\n\n| Source type | Count |\n|---|---:|\n| other-pdfs | 1 |\n| pages | 15 |\n| strategies | 1 |\n\n## Executive Readout\n\n### Purpose\n\n- Filter results\nYou can narrow down the results using the filters\nType\nCampaign\n(30)\nInitiative\n(303)\nProgram\n(85)\nReform\n(13)\nReview\n(25)\nAudience\nGeneral public\n(366)\nHealthcare workers\n(7)\nHealth professionals\n(76)\nIndustry\n(18)\nProviders\n(39)\nStudents and trainees\n(17)\nTopics\nAboriginal and Torres Strait Islander health\n(30)\nAboriginal and Torres Strait Islander health workforce\n(12)\nAbout the department\n(2)\nAged care\n(78)\nAged care workforce\n(15)\nAlcohol\n(3)\nAllied health care\n(17)\nBladder and bowel\n(4)\nBlood and blood products\n(2)\nCancer\n(16)\nChildren's health\n(14)\nChronic conditions\n(17)\nCommunicable diseases\n(6)\nDementia\n(12)\nDental health\n(1)\nDentists and dental practitioners\n(3)\nDisability and carers\n(35)\nDrugs\n(4)\nEar health and hearing\n(5)\nEmergency health management\n(5)\nEye health and vision\n(2)\nFamily, domestic and sexual violence\n(4)\nFood and nutrition\n(5)\nGeneral practice\n  Source: `pages/priorities-index.html (https://www.health.gov.au/our-work)`\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- Australia’s first Children’s Comprehensive Cancer Centre opens to deliver world leading cancer care\n6 May 2026\nMedia release\nIn an Australian first, children and young people with cancer, and their families, will benefit from world leading, comprehensive, research led clinical care in one fully integrated, purpose-built facility.\n  Source: `pages/ministers.html (https://www.health.gov.au/ministers)`\n\n### Role and Functions\n\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- [pages 1,2,3,4,5,6]\n[Page 1]\nStandard for AI\ntransparency\nstatements\nSupporting the policy for responsible\nuse of AI in government\nUse the following\ninformation to support\nyour agency’s\nimplementation of the\npolicy for responsible use\nof AI in government.\n  Source: `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf (https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf)`\n- Reportable Gifts and Benefits – 1 January to 31 March 2026\n28 April 2026\nDataset\nThis dataset reports gifts and benefits accepted in the performance of official duties that are valued over $100 (excluding GST), to meet whole‑of‑government reporting requirements set by the Australian Public Service Commission.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 2026 meetings\n9 October 2026\n19 June 2026\n13 March 2026\n2025 meetings\n31 October 2025\n25 July 2025\n6 March 2025\n2024 meetings\n13 December 2024\n28 June 2024\n16 February 2024\nSubmissions\nThe panel welcomes input from the public, including patients, carers, family members, treating physicians and advocates on upcoming items.\n  Source: `pages/homepage.html (https://www.health.gov.au/committees-and-groups/life-saving-drugs-program-expert-panel)`\n- Grant applications now open for the Support at Home Pooled Funding Trial\n28 April 2026\nNews\nUp to 10 eligible Support at Home providers will be selected to participate in a trial to test how flexible pooled funding models can support high-quality, person-centred in-home care.\n‘Vaccination is the best preparation’ campaign launches to promote winter vaccinations for older people\n27 April 2026\nNews\nWith the colder months approaching, the winter vaccination campaign has launched to promote the benefits of influenza, COVID-19 and respiratory syncytial virus (RSV) vaccination for older people.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n\n### Strategic Priorities\n\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- Department of Health, Disability and Ageing organisational chart\n24 April 2026\nInfographic\nThis chart shows the structure of the Department of Health, Disability and Ageing including our divisions, branches, statutory office holders and high priority taskforces.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- [pages 1,2,3,4,5,6]\n[Page 1]\nStandard for AI\ntransparency\nstatements\nSupporting the policy for responsible\nuse of AI in government\nUse the following\ninformation to support\nyour agency’s\nimplementation of the\npolicy for responsible use\nof AI in government.\n  Source: `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf (https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf)`\n- The agency’s accountable officials should provide the DTA with a link to the statement\nwhen it is published or updated by emailing ai@dta.gov.au\n2 APS Reform, Priority one: An APS that embodies integrity in everything it does. “The APS acts with integrity and fairness and\nis accountable and transparent in everything it does.\n  Source: `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf (https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf)`\n- Reportable Gifts and Benefits – 1 January to 31 March 2026\n28 April 2026\nDataset\nThis dataset reports gifts and benefits accepted in the performance of official duties that are valued over $100 (excluding GST), to meet whole‑of‑government reporting requirements set by the Australian Public Service Commission.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 2026 meetings\n9 October 2026\n19 June 2026\n13 March 2026\n2025 meetings\n31 October 2025\n25 July 2025\n6 March 2025\n2024 meetings\n13 December 2024\n28 June 2024\n16 February 2024\nSubmissions\nThe panel welcomes input from the public, including patients, carers, family members, treating physicians and advocates on upcoming items.\n  Source: `pages/homepage.html (https://www.health.gov.au/committees-and-groups/life-saving-drugs-program-expert-panel)`\n- Grant applications now open for the Support at Home Pooled Funding Trial\n28 April 2026\nNews\nUp to 10 eligible Support at Home providers will be selected to participate in a trial to test how flexible pooled funding models can support high-quality, person-centred in-home care.\n‘Vaccination is the best preparation’ campaign launches to promote winter vaccinations for older people\n27 April 2026\nNews\nWith the colder months approaching, the winter vaccination campaign has launched to promote the benefits of influenza, COVID-19 and respiratory syncytial virus (RSV) vaccination for older people.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n- Securing the NDIS for future generations\n22 April 2026\nNews\nThe Australian Government is taking steps to protect the National Disability Insurance Scheme (NDIS) for people with permanent and significant disability and for future generations who will rely on it.\n$23 million for research into Post-Acute Sequelae of COVID-19\n13 April 2026\nNews\nApply for the latest Medical Research Future Fund (MRFF) grant opportunity.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n- More than 3,700 practices registered in the Bulk Billing Practice Incentive Program\n10 April 2026\nNews\nThere are now more than 3,700 practices participating in the Bulk Billing Practice Incentive Program (BBPIP) across Australia.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n\n## KPIs, Targets, and Where They Are At\n\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- [pages 1,2,3,4,5,6]\n[Page 1]\nStandard for AI\ntransparency\nstatements\nSupporting the policy for responsible\nuse of AI in government\nUse the following\ninformation to support\nyour agency’s\nimplementation of the\npolicy for responsible use\nof AI in government.\n  Source: `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf (https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf)`\n- Reportable Gifts and Benefits – 1 January to 31 March 2026\n28 April 2026\nDataset\nThis dataset reports gifts and benefits accepted in the performance of official duties that are valued over $100 (excluding GST), to meet whole‑of‑government reporting requirements set by the Australian Public Service Commission.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 2026 meetings\n9 October 2026\n19 June 2026\n13 March 2026\n2025 meetings\n31 October 2025\n25 July 2025\n6 March 2025\n2024 meetings\n13 December 2024\n28 June 2024\n16 February 2024\nSubmissions\nThe panel welcomes input from the public, including patients, carers, family members, treating physicians and advocates on upcoming items.\n  Source: `pages/homepage.html (https://www.health.gov.au/committees-and-groups/life-saving-drugs-program-expert-panel)`\n- Grant applications now open for the Support at Home Pooled Funding Trial\n28 April 2026\nNews\nUp to 10 eligible Support at Home providers will be selected to participate in a trial to test how flexible pooled funding models can support high-quality, person-centred in-home care.\n‘Vaccination is the best preparation’ campaign launches to promote winter vaccinations for older people\n27 April 2026\nNews\nWith the colder months approaching, the winter vaccination campaign has launched to promote the benefits of influenza, COVID-19 and respiratory syncytial virus (RSV) vaccination for older people.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n- Securing the NDIS for future generations\n22 April 2026\nNews\nThe Australian Government is taking steps to protect the National Disability Insurance Scheme (NDIS) for people with permanent and significant disability and for future generations who will rely on it.\n$23 million for research into Post-Acute Sequelae of COVID-19\n13 April 2026\nNews\nApply for the latest Medical Research Future Fund (MRFF) grant opportunity.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n- More than 3,700 practices registered in the Bulk Billing Practice Incentive Program\n10 April 2026\nNews\nThere are now more than 3,700 practices participating in the Bulk Billing Practice Incentive Program (BBPIP) across Australia.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n- Filter results\nYou can narrow down the results using the filters\nType\nCampaign\n(30)\nInitiative\n(303)\nProgram\n(85)\nReform\n(13)\nReview\n(25)\nAudience\nGeneral public\n(366)\nHealthcare workers\n(7)\nHealth professionals\n(76)\nIndustry\n(18)\nProviders\n(39)\nStudents and trainees\n(17)\nTopics\nAboriginal and Torres Strait Islander health\n(30)\nAboriginal and Torres Strait Islander health workforce\n(12)\nAbout the department\n(2)\nAged care\n(78)\nAged care workforce\n(15)\nAlcohol\n(3)\nAllied health care\n(17)\nBladder and bowel\n(4)\nBlood and blood products\n(2)\nCancer\n(16)\nChildren's health\n(14)\nChronic conditions\n(17)\nCommunicable diseases\n(6)\nDementia\n(12)\nDental health\n(1)\nDentists and dental practitioners\n(3)\nDisability and carers\n(35)\nDrugs\n(4)\nEar health and hearing\n(5)\nEmergency health management\n(5)\nEye health and vision\n(2)\nFamily, domestic and sexual violence\n(4)\nFood and nutrition\n(5)\nGeneral practice\n  Source: `pages/priorities-index.html (https://www.health.gov.au/our-work)`\n- You can also call\n1800 200 422\nMonday to Friday, 8 am to 8 pm, and Saturday, 10 am to 2 pm.\n  Source: `pages/priorities-index__01.html (https://www.health.gov.au/our-work/aged-care-reforms?language=en)`\n- Subscribe\nNews\nNews\nTraining and professional development opportunities for aged care workers\n11 March 2026\nAged Care Provider Workforce Survey\n9 February 2026\nEOI: Support at Home pooled funding trial workshops\n29 October 2025\nView more news\nResources\nPrinciple 3 - Access the Outdoors: National Aged Care Design and Guidelines Webinar Series: Home Matters - Rethinking Aged Care Design\n30 April 2026\nPresentation\nThis webinar is for people working in aged care and design.\n  Source: `pages/priorities-index__01.html (https://www.health.gov.au/our-work/aged-care-reforms?language=en)`\n- [pages 1,2,3,4,5]\n[Page 1]\nProcedure guidance for medicines funded through the\nLife Saving Drugs Program (LSDP)\nVersion 1.0\nJuly 2018\nNote: Subject to revision by the LSDP Expert Panel\n1 | Procedure guidance for medicines funded through the LSDP\n  Source: `other-pdfs/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-ls.pdf (https://www.health.gov.au/sites/default/files/documents/2021/11/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-lsdp.pdf)`\n- Changes to the program from 1 July 2018 include:\n• the adoption of a rare diseases definition, that being a disease prevalence of\n1:50,000 people or less in the Australian population (around 500 people).\n  Source: `other-pdfs/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-ls.pdf (https://www.health.gov.au/sites/default/files/documents/2021/11/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-lsdp.pdf)`\n- [Page 2]\nStandard for AI transparency statements\nDigital Transformation Agency\n© Commonwealth of Australia (Digital Transformation Agency) 2024 | Version 1801\nWith the exception of the Commonwealth Coat of Arms and where otherwise noted, this\nproduct is provided under a Creative Commons Attribution 4.0 International Licence.\n(http://creativecommons.org/licenses/by/4.0/legalcode)\nThe Digital Transformation Agency has tried to make the information in this product\nas accurate as possible.\n  Source: `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf (https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf)`\n\n## Key Metrics\n\n| Values found | Evidence | Source |\n|---|---|---|\n| $23 million, 23 million | Securing the NDIS for future generations\n22 April 2026\nNews\nThe Australian Government is taking steps to protect the National Disability Insurance Scheme (NDIS) for people with permanent and significant disability and for future generations who will rely on it.\n$23 million for research into Post-Acute Sequelae of COVID-19\n13 April 2026\nNews\nApply for the latest Medical Research Future Fund (MRFF) grant opportunity. | `pages/news-latest.html (https://www.health.gov.au/news)` |\n| $74 million, 74 million | Have your say on the aged care reforms\n23 March 2026\nNews\nThe Aged Care Reform Sector Pulse Survey is your opportunity to share your feedback about the implementation of the aged care reforms.\n$74 million to drive genomic health research\n19 March 2026\nNews\nRead about the latest Medical Research Future Fund (MRFF) grant opportunity. | `pages/news-latest.html (https://www.health.gov.au/news)` |\n| $100 | Reportable Gifts and Benefits – 1 January to 31 March 2026\n28 April 2026\nDataset\nThis dataset reports gifts and benefits accepted in the performance of official duties that are valued over $100 (excluding GST), to meet whole‑of‑government reporting requirements set by the Australian Public Service Commission. | `pages/about.html (https://www.health.gov.au/topics/about-the-department)` |\n| 2 APS | The agency’s accountable officials should provide the DTA with a link to the statement\nwhen it is published or updated by emailing ai@dta.gov.au\n2 APS Reform, Priority one: An APS that embodies integrity in everything it does. “The APS acts with integrity and fairness and\nis accountable and transparent in everything it does. | `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf (https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf)` |\n| $100 | Reportable Gifts and Benefits – 1 January to 31 March 2026\n28 April 2026\nDataset\nThis dataset reports gifts and benefits accepted in the performance of official duties that are valued over $100 (excluding GST), to meet whole‑of‑government reporting requirements set by the Australian Public Service Commission. | `pages/about.html (https://www.health.gov.au/topics/about-the-department)` |\n| $23 million, 23 million | Securing the NDIS for future generations\n22 April 2026\nNews\nThe Australian Government is taking steps to protect the National Disability Insurance Scheme (NDIS) for people with permanent and significant disability and for future generations who will rely on it.\n$23 million for research into Post-Acute Sequelae of COVID-19\n13 April 2026\nNews\nApply for the latest Medical Research Future Fund (MRFF) grant opportunity. | `pages/news-latest.html (https://www.health.gov.au/news)` |\n| $74 million, 74 million | Have your say on the aged care reforms\n23 March 2026\nNews\nThe Aged Care Reform Sector Pulse Survey is your opportunity to share your feedback about the implementation of the aged care reforms.\n$74 million to drive genomic health research\n19 March 2026\nNews\nRead about the latest Medical Research Future Fund (MRFF) grant opportunity. | `pages/news-latest.html (https://www.health.gov.au/news)` |\n\n## Key Achievements\n\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- [pages 1,2,3,4,5,6]\n[Page 1]\nStandard for AI\ntransparency\nstatements\nSupporting the policy for responsible\nuse of AI in government\nUse the following\ninformation to support\nyour agency’s\nimplementation of the\npolicy for responsible use\nof AI in government.\n  Source: `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf (https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf)`\n- Reportable Gifts and Benefits – 1 January to 31 March 2026\n28 April 2026\nDataset\nThis dataset reports gifts and benefits accepted in the performance of official duties that are valued over $100 (excluding GST), to meet whole‑of‑government reporting requirements set by the Australian Public Service Commission.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 2026 meetings\n9 October 2026\n19 June 2026\n13 March 2026\n2025 meetings\n31 October 2025\n25 July 2025\n6 March 2025\n2024 meetings\n13 December 2024\n28 June 2024\n16 February 2024\nSubmissions\nThe panel welcomes input from the public, including patients, carers, family members, treating physicians and advocates on upcoming items.\n  Source: `pages/homepage.html (https://www.health.gov.au/committees-and-groups/life-saving-drugs-program-expert-panel)`\n- Grant applications now open for the Support at Home Pooled Funding Trial\n28 April 2026\nNews\nUp to 10 eligible Support at Home providers will be selected to participate in a trial to test how flexible pooled funding models can support high-quality, person-centred in-home care.\n‘Vaccination is the best preparation’ campaign launches to promote winter vaccinations for older people\n27 April 2026\nNews\nWith the colder months approaching, the winter vaccination campaign has launched to promote the benefits of influenza, COVID-19 and respiratory syncytial virus (RSV) vaccination for older people.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n- Securing the NDIS for future generations\n22 April 2026\nNews\nThe Australian Government is taking steps to protect the National Disability Insurance Scheme (NDIS) for people with permanent and significant disability and for future generations who will rely on it.\n$23 million for research into Post-Acute Sequelae of COVID-19\n13 April 2026\nNews\nApply for the latest Medical Research Future Fund (MRFF) grant opportunity.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n- More than 3,700 practices registered in the Bulk Billing Practice Incentive Program\n10 April 2026\nNews\nThere are now more than 3,700 practices participating in the Bulk Billing Practice Incentive Program (BBPIP) across Australia.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n- Filter results\nYou can narrow down the results using the filters\nType\nCampaign\n(30)\nInitiative\n(303)\nProgram\n(85)\nReform\n(13)\nReview\n(25)\nAudience\nGeneral public\n(366)\nHealthcare workers\n(7)\nHealth professionals\n(76)\nIndustry\n(18)\nProviders\n(39)\nStudents and trainees\n(17)\nTopics\nAboriginal and Torres Strait Islander health\n(30)\nAboriginal and Torres Strait Islander health workforce\n(12)\nAbout the department\n(2)\nAged care\n(78)\nAged care workforce\n(15)\nAlcohol\n(3)\nAllied health care\n(17)\nBladder and bowel\n(4)\nBlood and blood products\n(2)\nCancer\n(16)\nChildren's health\n(14)\nChronic conditions\n(17)\nCommunicable diseases\n(6)\nDementia\n(12)\nDental health\n(1)\nDentists and dental practitioners\n(3)\nDisability and carers\n(35)\nDrugs\n(4)\nEar health and hearing\n(5)\nEmergency health management\n(5)\nEye health and vision\n(2)\nFamily, domestic and sexual violence\n(4)\nFood and nutrition\n(5)\nGeneral practice\n  Source: `pages/priorities-index.html (https://www.health.gov.au/our-work)`\n- You can also call\n1800 200 422\nMonday to Friday, 8 am to 8 pm, and Saturday, 10 am to 2 pm.\n  Source: `pages/priorities-index__01.html (https://www.health.gov.au/our-work/aged-care-reforms?language=en)`\n- Subscribe\nNews\nNews\nTraining and professional development opportunities for aged care workers\n11 March 2026\nAged Care Provider Workforce Survey\n9 February 2026\nEOI: Support at Home pooled funding trial workshops\n29 October 2025\nView more news\nResources\nPrinciple 3 - Access the Outdoors: National Aged Care Design and Guidelines Webinar Series: Home Matters - Rethinking Aged Care Design\n30 April 2026\nPresentation\nThis webinar is for people working in aged care and design.\n  Source: `pages/priorities-index__01.html (https://www.health.gov.au/our-work/aged-care-reforms?language=en)`\n- [pages 1,2,3,4,5]\n[Page 1]\nProcedure guidance for medicines funded through the\nLife Saving Drugs Program (LSDP)\nVersion 1.0\nJuly 2018\nNote: Subject to revision by the LSDP Expert Panel\n1 | Procedure guidance for medicines funded through the LSDP\n  Source: `other-pdfs/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-ls.pdf (https://www.health.gov.au/sites/default/files/documents/2021/11/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-lsdp.pdf)`\n\n## Key Issues, Risks, and Recommendations\n\n- [Page 23]\n• measures to improve cost-effectiveness, including pay-for-performance or other risk\nsharing arrangements\n• changes to ongoing data collection requirements\n• education for health professionals or consumers\n• future review\n• referral to PBAC for consideration for PBS listing\nSponsors of the medicine/s involved in the review are provided with the Expert Panel advice and\nrecommendations.\n  Source: `other-pdfs/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-ls.pdf (https://www.health.gov.au/sites/default/files/documents/2021/11/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-lsdp.pdf)`\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- During the 2024-25 financial year, we acted to further strengthen our compliance with the\nCommonwealth Child Safe Framework\nand to minimise key risks, including:\nreviewing and updating the Department's Child Safety Policy, with additional guidance about risk management and working with children check requirements for all Australian jurisdictions\nproviding additional guidance information about child safety risks for departmental staff undertaking annual risk assessment processes\nmaturity self-assessment to identify areas for improvement aligned to annual risk assessment processes\nOur divisional business and risk planning process includes an annual risk assessment regarding the level of direct or indirect contact with children across our department.\n  Source: `pages/announcements-index__04.html (https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/child-safety)`\n- [pages 1,2,3,4,5,6]\n[Page 1]\nStandard for AI\ntransparency\nstatements\nSupporting the policy for responsible\nuse of AI in government\nUse the following\ninformation to support\nyour agency’s\nimplementation of the\npolicy for responsible use\nof AI in government.\n  Source: `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf (https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf)`\n- Reportable Gifts and Benefits – 1 January to 31 March 2026\n28 April 2026\nDataset\nThis dataset reports gifts and benefits accepted in the performance of official duties that are valued over $100 (excluding GST), to meet whole‑of‑government reporting requirements set by the Australian Public Service Commission.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- In continuing to comply with the Framework and 10 National Principles, while leveraging the outcome of our annual risk assessment, our key initiatives include:\nimproving staff awareness of the department’s Child Safety Policy and their obligations under the policy\nour senior executive continuing to support and promote the application of the Child Safety Policy across our department\nensuring child safe clauses are included in grants or procurement documents for funded third parties where required\nensuring relevant staff complete required training and get and/or maintain relevant checks where required.\n  Source: `pages/announcements-index__04.html (https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/child-safety)`\n- 2026 meetings\n9 October 2026\n19 June 2026\n13 March 2026\n2025 meetings\n31 October 2025\n25 July 2025\n6 March 2025\n2024 meetings\n13 December 2024\n28 June 2024\n16 February 2024\nSubmissions\nThe panel welcomes input from the public, including patients, carers, family members, treating physicians and advocates on upcoming items.\n  Source: `pages/homepage.html (https://www.health.gov.au/committees-and-groups/life-saving-drugs-program-expert-panel)`\n- Grant applications now open for the Support at Home Pooled Funding Trial\n28 April 2026\nNews\nUp to 10 eligible Support at Home providers will be selected to participate in a trial to test how flexible pooled funding models can support high-quality, person-centred in-home care.\n‘Vaccination is the best preparation’ campaign launches to promote winter vaccinations for older people\n27 April 2026\nNews\nWith the colder months approaching, the winter vaccination campaign has launched to promote the benefits of influenza, COVID-19 and respiratory syncytial virus (RSV) vaccination for older people.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n- Securing the NDIS for future generations\n22 April 2026\nNews\nThe Australian Government is taking steps to protect the National Disability Insurance Scheme (NDIS) for people with permanent and significant disability and for future generations who will rely on it.\n$23 million for research into Post-Acute Sequelae of COVID-19\n13 April 2026\nNews\nApply for the latest Medical Research Future Fund (MRFF) grant opportunity.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n- New phase of ‘Medicare Urgent Care Clinics’ campaign launches to help more Australians access urgent care in their community\n13 April 2026\nNews\nThe Australian government has launched phase 3 of the ‘Medicare Urgent Care Clinics’ campaign, to help raise awareness of new clinics that provide accessible, bulk-billed care for urgent but non-life threatening health issues.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n- More than 3,700 practices registered in the Bulk Billing Practice Incentive Program\n10 April 2026\nNews\nThere are now more than 3,700 practices participating in the Bulk Billing Practice Incentive Program (BBPIP) across Australia.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n- Filter results\nYou can narrow down the results using the filters\nType\nCampaign\n(30)\nInitiative\n(303)\nProgram\n(85)\nReform\n(13)\nReview\n(25)\nAudience\nGeneral public\n(366)\nHealthcare workers\n(7)\nHealth professionals\n(76)\nIndustry\n(18)\nProviders\n(39)\nStudents and trainees\n(17)\nTopics\nAboriginal and Torres Strait Islander health\n(30)\nAboriginal and Torres Strait Islander health workforce\n(12)\nAbout the department\n(2)\nAged care\n(78)\nAged care workforce\n(15)\nAlcohol\n(3)\nAllied health care\n(17)\nBladder and bowel\n(4)\nBlood and blood products\n(2)\nCancer\n(16)\nChildren's health\n(14)\nChronic conditions\n(17)\nCommunicable diseases\n(6)\nDementia\n(12)\nDental health\n(1)\nDentists and dental practitioners\n(3)\nDisability and carers\n(35)\nDrugs\n(4)\nEar health and hearing\n(5)\nEmergency health management\n(5)\nEye health and vision\n(2)\nFamily, domestic and sexual violence\n(4)\nFood and nutrition\n(5)\nGeneral practice\n  Source: `pages/priorities-index.html (https://www.health.gov.au/our-work)`\n- You can also call\n1800 200 422\nMonday to Friday, 8 am to 8 pm, and Saturday, 10 am to 2 pm.\n  Source: `pages/priorities-index__01.html (https://www.health.gov.au/our-work/aged-care-reforms?language=en)`\n\n## Corporate Values and Operating Culture\n\n- Reportable Gifts and Benefits – 1 January to 31 March 2026\n28 April 2026\nDataset\nThis dataset reports gifts and benefits accepted in the performance of official duties that are valued over $100 (excluding GST), to meet whole‑of‑government reporting requirements set by the Australian Public Service Commission.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- Filter results\nYou can narrow down the results using the filters\nType\nCampaign\n(30)\nInitiative\n(303)\nProgram\n(85)\nReform\n(13)\nReview\n(25)\nAudience\nGeneral public\n(366)\nHealthcare workers\n(7)\nHealth professionals\n(76)\nIndustry\n(18)\nProviders\n(39)\nStudents and trainees\n(17)\nTopics\nAboriginal and Torres Strait Islander health\n(30)\nAboriginal and Torres Strait Islander health workforce\n(12)\nAbout the department\n(2)\nAged care\n(78)\nAged care workforce\n(15)\nAlcohol\n(3)\nAllied health care\n(17)\nBladder and bowel\n(4)\nBlood and blood products\n(2)\nCancer\n(16)\nChildren's health\n(14)\nChronic conditions\n(17)\nCommunicable diseases\n(6)\nDementia\n(12)\nDental health\n(1)\nDentists and dental practitioners\n(3)\nDisability and carers\n(35)\nDrugs\n(4)\nEar health and hearing\n(5)\nEmergency health management\n(5)\nEye health and vision\n(2)\nFamily, domestic and sexual violence\n(4)\nFood and nutrition\n(5)\nGeneral practice\n  Source: `pages/priorities-index.html (https://www.health.gov.au/our-work)`\n- Subscribe\nNews\nNews\nTraining and professional development opportunities for aged care workers\n11 March 2026\nAged Care Provider Workforce Survey\n9 February 2026\nEOI: Support at Home pooled funding trial workshops\n29 October 2025\nView more news\nResources\nPrinciple 3 - Access the Outdoors: National Aged Care Design and Guidelines Webinar Series: Home Matters - Rethinking Aged Care Design\n30 April 2026\nPresentation\nThis webinar is for people working in aged care and design.\n  Source: `pages/priorities-index__01.html (https://www.health.gov.au/our-work/aged-care-reforms?language=en)`\n- View all information about the department\nLatest news\nLatest news\nBudget 2025–26 information\n25 March 2025\nDepartment of Health and Aged Care Statement\nProfessor Michael Kidd AO, MBBS, MD, FAHMS, FRACGP has been appointed as Australia’s new Chief Medical Officer from 1 June 2025.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- 19 March 2025\nBudget 2024–25 information\n14 May 2024\nView more corporate news\nCorporate initiatives and programs\nGraduate Program\nOur graduate program starts in February each year and is based in Canberra.\n  Source: `pages/about.html (https://www.health.gov.au/topics/about-the-department)`\n- How we use AI\nFrom 1 January 2024 to 30 June 2024, we participated in the Australian Government’s trials of a generative AI service, Microsoft 365 Copilot.\n  Source: `pages/announcements-index.html (https://www.health.gov.au/about-us/corporate-reporting/our-commitments/ai-transparency-statement)`\n- Hearing Service Program Provider notice 2026-02 – Fully subsidised hearing devices for CROS/BiCROS fitting configuration\n2 April 2026\nNews\nService providers who work under the Australian Government Hearing Services Program must follow the rules in their contract and the laws that apply to the program.\n  Source: `pages/news-latest.html (https://www.health.gov.au/news)`\n- [pages 1,2,3,4,5,6]\n[Page 1]\nStandard for AI\ntransparency\nstatements\nSupporting the policy for responsible\nuse of AI in government\nUse the following\ninformation to support\nyour agency’s\nimplementation of the\npolicy for responsible use\nof AI in government.\n  Source: `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf (https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf)`\n\n## Global Ideas and Case Study Inputs\n\n_No global-intelligence source text found yet. Run `CLAUDE/global-ideas-scraper.py <entity>` to populate case-study sources._\n\n## Source Artifacts Used\n\n- `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf` - strategies - https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf\n- `pages/about.html` - pages - https://www.health.gov.au/topics/about-the-department\n- `pages/announcements-index.html` - pages - https://www.health.gov.au/about-us/corporate-reporting/our-commitments/ai-transparency-statement\n- `pages/announcements-index__02.html` - pages - https://www.health.gov.au/about-us/corporate-reporting/our-commitments/ai-transparency-statement\n- `pages/announcements-index__03.html` - pages - https://www.health.gov.au/about-us/corporate-reporting/our-commitments/ai-transparency-statement?language=en\n- `pages/announcements-index__04.html` - pages - https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/child-safety\n- `pages/announcements-index__05.html` - pages - https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/regulator-statement\n- `pages/announcements-index__06.html` - pages - https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/workplace-gender-equality-agency-employer-statement\n- `pages/contact.html` - pages - https://www.health.gov.au/contacts/life-saving-drugs-program-expert-panel-secretariat\n- `pages/corporate-plans-index.html` - pages - https://www.health.gov.au/resources/publications/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-lsdp\n- `pages/homepage.html` - pages - https://www.health.gov.au/committees-and-groups/life-saving-drugs-program-expert-panel\n- `pages/ministers.html` - pages - https://www.health.gov.au/ministers\n- `pages/news-latest.html` - pages - https://www.health.gov.au/news\n- `pages/priorities-index.html` - pages - https://www.health.gov.au/our-work\n- `pages/priorities-index__01.html` - pages - https://www.health.gov.au/our-work/aged-care-reforms?language=en\n- `pages/publications-index.html` - pages - https://www.health.gov.au/resources/publications/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-lsdp\n- `other-pdfs/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-ls.pdf` - other-pdfs - https://www.health.gov.au/sites/default/files/documents/2021/11/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-lsdp.pdf\n\n## Gaps To Fix\n\n- No corporate plan text source found.\n- No annual report text source found.\n- No global comparison/case-study sources found.",
  "legislation_md": "# Life Saving Drugs Program Expert Panel - Acts and Legislation Discovery\n\n**Generated at**: 2026-05-09T21:09:11.197535+00:00\n**Entity ID**: B-001022\n**Jurisdiction**: Commonwealth\n**Portfolio**: Health, Disability and Ageing\n\n> This is an evidence-based discovery list from scraped department material. A mention does not always mean the department administers the legislation; high-confidence and official register links should be reviewed.\n\n## Summary\n\n- Source files scanned: 17\n- Unique legislation references found: 0\n\n## Legislation References\n\n_No Act/Regulation/Instrument references found in the local corpus._\n\n## Files Scanned\n\n- `pages/about.html` (page)\n- `pages/announcements-index.html` (page)\n- `pages/announcements-index__02.html` (page)\n- `pages/announcements-index__03.html` (page)\n- `pages/announcements-index__04.html` (page)\n- `pages/announcements-index__05.html` (page)\n- `pages/announcements-index__06.html` (page)\n- `pages/contact.html` (page)\n- `pages/corporate-plans-index.html` (page)\n- `pages/homepage.html` (page)\n- `pages/ministers.html` (page)\n- `pages/news-latest.html` (page)\n- `pages/priorities-index.html` (page)\n- `pages/priorities-index__01.html` (page)\n- `pages/publications-index.html` (page)\n- `other-pdfs/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-ls.pages.jsonl` (pdf_pages)\n- `strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pages.jsonl` (pdf_pages)",
  "global_initiatives_md": null,
  "strategy": {
    "reporting_period": "2024-25",
    "corporate_plan_period": "2025-26",
    "vision": null,
    "vision_source_page": null,
    "purposes": null,
    "purposes_source_page": null,
    "how_we_deliver": null,
    "how_we_deliver_source_page": null,
    "government_priorities": [],
    "outcomes": [],
    "values": [],
    "values_framework_name": null,
    "kpi_targets_2025_26": [],
    "kpi_results_2024_25": [],
    "_source_urls": {
      "annual_report_url": "",
      "corporate_plan_url": ""
    }
  },
  "ideas": [
    {
      "entity_id": "B-001022",
      "entity_name": "Life Saving Drugs Program Expert Panel",
      "folder_name": "Life-Saving-Drugs-Program-Expert-Panel",
      "category": "Citizen Services",
      "scale": "small",
      "title": "Plain-language service pages and proactive status updates",
      "idea": "Rewrite high-volume pages and letters into plain language, add status notifications, and measure contact reduction.",
      "quote": "[Page 2]\nStandard for AI transparency statements\nDigital Transformation Agency\n© Commonwealth of Australia (Digital Transformation Agency) 2024 | Version 1801\nWith the exception of the Commonwealth Coat of Arms and where otherwise noted, this\nproduct is provided under a Creative Commons Attribution 4.0 International Licence.\n(http://creativecommons.org/licenses/by/4.0/legalcode)\nThe Digital Transformation Agency has tried to make the information in this product\nas accurate as possible.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Citizens / service users",
      "source": "strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf (https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Digital exclusion",
        "Low public trust if feedback is not acted on"
      ]
    },
    {
      "entity_id": "B-001022",
      "entity_name": "Life Saving Drugs Program Expert Panel",
      "folder_name": "Life-Saving-Drugs-Program-Expert-Panel",
      "category": "Citizen Services",
      "scale": "large",
      "title": "Single front door for life-event based services",
      "idea": "Bundle services around life events so citizens can complete related steps across agencies in one journey.",
      "quote": "[Page 2]\nStandard for AI transparency statements\nDigital Transformation Agency\n© Commonwealth of Australia (Digital Transformation Agency) 2024 | Version 1801\nWith the exception of the Commonwealth Coat of Arms and where otherwise noted, this\nproduct is provided under a Creative Commons Attribution 4.0 International Licence.\n(http://creativecommons.org/licenses/by/4.0/legalcode)\nThe Digital Transformation Agency has tried to make the information in this product\nas accurate as possible.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Citizens / service users",
      "source": "strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf (https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Digital exclusion",
        "Low public trust if feedback is not acted on"
      ]
    },
    {
      "entity_id": "B-001022",
      "entity_name": "Life Saving Drugs Program Expert Panel",
      "folder_name": "Life-Saving-Drugs-Program-Expert-Panel",
      "category": "Data & Performance",
      "scale": "small",
      "title": "KPI evidence register with named owners",
      "idea": "Create a simple register mapping each KPI to source data, owner, frequency, target, and last result.",
      "quote": "This could include (but should not be limited to) uncertainty around:\n• Treatment guidelines (including eligibility criteria, dosage amount and frequency)\n• Life extension/survival benefit\n• Clinical effectiveness in terms of surrogate outcomes\n• Medicine safety\n• Reliability of diagnostic test\n• Extent of use\n• Patient relevant outcomes\nA proposal for managing uncertainty should include:\n• Proposed price of the medicine\n• Areas of uncertainty\n• Timeframe for evidence collection\n• Pre-determined pricing consequences of updated evidence gathered (if required)\nIn its review of the application, the LSDP Expert Panel will provide advice about sources of\nuncertainty based on issues identified in the application and the proposals from the sponsor\nto address, and make recommendations about how these can be addressed through further\ndata collection.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Executives / Parliament / public",
      "source": "other-pdfs/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-ls.pdf (https://www.health.gov.au/sites/default/files/documents/2021/11/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-lsdp.pdf)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability"
      ]
    },
    {
      "entity_id": "B-001022",
      "entity_name": "Life Saving Drugs Program Expert Panel",
      "folder_name": "Life-Saving-Drugs-Program-Expert-Panel",
      "category": "Data & Performance",
      "scale": "large",
      "title": "Outcome dashboard linking budget, delivery, and public impact",
      "idea": "Build a public-facing outcome dashboard showing spend, outputs, outcomes, and delivery confidence.",
      "quote": "This could include (but should not be limited to) uncertainty around:\n• Treatment guidelines (including eligibility criteria, dosage amount and frequency)\n• Life extension/survival benefit\n• Clinical effectiveness in terms of surrogate outcomes\n• Medicine safety\n• Reliability of diagnostic test\n• Extent of use\n• Patient relevant outcomes\nA proposal for managing uncertainty should include:\n• Proposed price of the medicine\n• Areas of uncertainty\n• Timeframe for evidence collection\n• Pre-determined pricing consequences of updated evidence gathered (if required)\nIn its review of the application, the LSDP Expert Panel will provide advice about sources of\nuncertainty based on issues identified in the application and the proposals from the sponsor\nto address, and make recommendations about how these can be addressed through further\ndata collection.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Executives / Parliament / public",
      "source": "other-pdfs/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-ls.pdf (https://www.health.gov.au/sites/default/files/documents/2021/11/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-lsdp.pdf)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability"
      ]
    },
    {
      "entity_id": "B-001022",
      "entity_name": "Life Saving Drugs Program Expert Panel",
      "folder_name": "Life-Saving-Drugs-Program-Expert-Panel",
      "category": "Staff Productivity",
      "scale": "small",
      "title": "Reusable briefing and summary assistant for internal documents",
      "idea": "Create controlled templates for summarising reports, submissions, minutes, and ministerial briefs.",
      "quote": "We have made Copilot Chat available to all staff and are rolling out Microsoft 365 Copilot licenced version to staff in phases.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "APS staff / executives",
      "source": "pages/announcements-index.html (https://www.health.gov.au/about-us/corporate-reporting/our-commitments/ai-transparency-statement)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Sensitive information leakage",
        "Inconsistent quality of generated drafts"
      ]
    },
    {
      "entity_id": "B-001022",
      "entity_name": "Life Saving Drugs Program Expert Panel",
      "folder_name": "Life-Saving-Drugs-Program-Expert-Panel",
      "category": "Staff Productivity",
      "scale": "large",
      "title": "Department-wide knowledge and briefing platform",
      "idea": "Build a secure knowledge platform that lets staff search, summarise, and cite approved departmental material.",
      "quote": "We have made Copilot Chat available to all staff and are rolling out Microsoft 365 Copilot licenced version to staff in phases.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "APS staff / executives",
      "source": "pages/announcements-index.html (https://www.health.gov.au/about-us/corporate-reporting/our-commitments/ai-transparency-statement)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Sensitive information leakage",
        "Inconsistent quality of generated drafts"
      ]
    },
    {
      "entity_id": "B-001022",
      "entity_name": "Life Saving Drugs Program Expert Panel",
      "folder_name": "Life-Saving-Drugs-Program-Expert-Panel",
      "category": "Regulation & Policy",
      "scale": "small",
      "title": "Regulatory burden scan for forms, guidance, and reporting",
      "idea": "Identify the top 10 highest-friction reporting obligations and simplify guidance, forms, or evidence requirements.",
      "quote": "In continuing to comply with the Framework and 10 National Principles, while leveraging the outcome of our annual risk assessment, our key initiatives include:\nimproving staff awareness of the department’s Child Safety Policy and their obligations under the policy\nour senior executive continuing to support and promote the application of the Child Safety Policy across our department\nensuring child safe clauses are included in grants or procurement documents for funded third parties where required\nensuring relevant staff complete required training and get and/or maintain relevant checks where required.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Regulated entities / policy teams",
      "source": "pages/announcements-index__04.html (https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/child-safety)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Regulatory capture",
        "Over-automation of judgement"
      ]
    },
    {
      "entity_id": "B-001022",
      "entity_name": "Life Saving Drugs Program Expert Panel",
      "folder_name": "Life-Saving-Drugs-Program-Expert-Panel",
      "category": "Regulation & Policy",
      "scale": "large",
      "title": "Adaptive regulation program with live feedback loops",
      "idea": "Create an adaptive regulation model using sandboxes, industry data, risk scoring, and regular rule updates.",
      "quote": "In continuing to comply with the Framework and 10 National Principles, while leveraging the outcome of our annual risk assessment, our key initiatives include:\nimproving staff awareness of the department’s Child Safety Policy and their obligations under the policy\nour senior executive continuing to support and promote the application of the Child Safety Policy across our department\nensuring child safe clauses are included in grants or procurement documents for funded third parties where required\nensuring relevant staff complete required training and get and/or maintain relevant checks where required.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Regulated entities / policy teams",
      "source": "pages/announcements-index__04.html (https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/child-safety)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Regulatory capture",
        "Over-automation of judgement"
      ]
    },
    {
      "entity_id": "B-001022",
      "entity_name": "Life Saving Drugs Program Expert Panel",
      "folder_name": "Life-Saving-Drugs-Program-Expert-Panel",
      "category": "Risk & Assurance",
      "scale": "small",
      "title": "Recommendation tracker for audits, reviews, and inquiries",
      "idea": "Publish a single internal tracker for audit/review recommendations, owners, due dates, and implementation evidence.",
      "quote": "During the 2024-25 financial year, we acted to further strengthen our compliance with the\nCommonwealth Child Safe Framework\nand to minimise key risks, including:\nreviewing and updating the Department's Child Safety Policy, with additional guidance about risk management and working with children check requirements for all Australian jurisdictions\nproviding additional guidance information about child safety risks for departmental staff undertaking annual risk assessment processes\nmaturity self-assessment to identify areas for improvement aligned to annual risk assessment processes\nOur divisional business and risk planning process includes an annual risk assessment regarding the level of direct or indirect contact with children across our department.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Executives / assurance teams",
      "source": "pages/announcements-index__04.html (https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/child-safety)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Regulatory capture",
        "Over-automation of judgement"
      ]
    },
    {
      "entity_id": "B-001022",
      "entity_name": "Life Saving Drugs Program Expert Panel",
      "folder_name": "Life-Saving-Drugs-Program-Expert-Panel",
      "category": "Risk & Assurance",
      "scale": "large",
      "title": "Integrated assurance and lessons-learned system",
      "idea": "Create an assurance system that connects audit findings, risk registers, delivery reviews, and investment decisions.",
      "quote": "During the 2024-25 financial year, we acted to further strengthen our compliance with the\nCommonwealth Child Safe Framework\nand to minimise key risks, including:\nreviewing and updating the Department's Child Safety Policy, with additional guidance about risk management and working with children check requirements for all Australian jurisdictions\nproviding additional guidance information about child safety risks for departmental staff undertaking annual risk assessment processes\nmaturity self-assessment to identify areas for improvement aligned to annual risk assessment processes\nOur divisional business and risk planning process includes an annual risk assessment regarding the level of direct or indirect contact with children across our department.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Executives / assurance teams",
      "source": "pages/announcements-index__04.html (https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/child-safety)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Regulatory capture",
        "Over-automation of judgement"
      ]
    },
    {
      "entity_id": "B-001022",
      "entity_name": "Life Saving Drugs Program Expert Panel",
      "folder_name": "Life-Saving-Drugs-Program-Expert-Panel",
      "category": "Case Processing",
      "scale": "small",
      "title": "Triage queue for stuck or ageing cases",
      "idea": "Use existing case data to flag ageing, duplicate, incomplete, or high-risk cases for earlier intervention.",
      "quote": "During the 2024-25 financial year, we acted to further strengthen our compliance with the\nCommonwealth Child Safe Framework\nand to minimise key risks, including:\nreviewing and updating the Department's Child Safety Policy, with additional guidance about risk management and working with children check requirements for all Australian jurisdictions\nproviding additional guidance information about child safety risks for departmental staff undertaking annual risk assessment processes\nmaturity self-assessment to identify areas for improvement aligned to annual risk assessment processes\nOur divisional business and risk planning process includes an annual risk assessment regarding the level of direct or indirect contact with children across our department.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Applicants / case officers",
      "source": "pages/announcements-index__04.html (https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/child-safety)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability"
      ]
    },
    {
      "entity_id": "B-001022",
      "entity_name": "Life Saving Drugs Program Expert Panel",
      "folder_name": "Life-Saving-Drugs-Program-Expert-Panel",
      "category": "Case Processing",
      "scale": "large",
      "title": "End-to-end case processing redesign",
      "idea": "Redesign the case pathway around risk-based triage, reusable evidence, and automated eligibility checks.",
      "quote": "During the 2024-25 financial year, we acted to further strengthen our compliance with the\nCommonwealth Child Safe Framework\nand to minimise key risks, including:\nreviewing and updating the Department's Child Safety Policy, with additional guidance about risk management and working with children check requirements for all Australian jurisdictions\nproviding additional guidance information about child safety risks for departmental staff undertaking annual risk assessment processes\nmaturity self-assessment to identify areas for improvement aligned to annual risk assessment processes\nOur divisional business and risk planning process includes an annual risk assessment regarding the level of direct or indirect contact with children across our department.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Applicants / case officers",
      "source": "pages/announcements-index__04.html (https://www.health.gov.au/topics/about-the-department/corporate-reporting/our-commitments/child-safety)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability"
      ]
    }
  ],
  "legislation_administered": [],
  "artifacts": [
    {
      "category": "strategies",
      "year": "2024",
      "url": "https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf",
      "file": "strategies/Standard-20for-20AI-20transparency-20statements-20v1.1.pdf",
      "bytes": 289017,
      "link_text": "Standard for AI transparency statements"
    },
    {
      "category": "other-pdfs",
      "year": "2021",
      "url": "https://www.health.gov.au/sites/default/files/documents/2021/11/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-lsdp.pdf",
      "file": "other-pdfs/procedure-guidance-for-medicines-funded-through-the-life-saving-drugs-program-ls.pdf",
      "bytes": 687889,
      "link_text": "Procedure guidance for medicines funded through the Life Saving Drugs Program (LSDP) [PDF - 672 KB] - 30 pages"
    }
  ],
  "_meta": {
    "snapshot_built_at": "2026-05-13T11:02:53+00:00",
    "strategy_brief_meta": {
      "model": "nova-micro",
      "folder": "Life-Saving-Drugs-Program-Expert-Panel",
      "annual_report": {
        "file": null,
        "url": "",
        "year": null
      },
      "corporate_plan": {
        "file": "strategies\\Standard-20for-20AI-20transparency-20statements-20v1.1.txt",
        "url": "https://www.digital.gov.au/sites/default/files/documents/2024-08/Standard%20for%20AI%20transparency%20statements%20v1.1.pdf",
        "year": null
      },
      "usage": {
        "input_tokens": 2799,
        "output_tokens": 155,
        "total_tokens": 2954,
        "model": "nova-micro"
      },
      "cost_usd": 0.000119665,
      "elapsed_seconds": 4.76,
      "generated_at": "2026-05-13T05:17:27+00:00"
    },
    "ideas_manifest": {
      "entity_id": "B-001022",
      "entity_name": "Life Saving Drugs Program Expert Panel",
      "folder_name": "Life-Saving-Drugs-Program-Expert-Panel",
      "generated_at": "2026-05-09T23:05:36.649805+00:00",
      "idea_count": 12,
      "markdown": "ideas/Life-Saving-Drugs-Program-Expert-Panel_ideas.md",
      "jsonl": "ideas/ideas.jsonl",
      "inputs": [
        "Life-Saving-Drugs-Program-Expert-Panel_strategy-overview.md",
        "strategy-evidence.json",
        "global-intelligence/source-manifest.json"
      ]
    },
    "global_intel_meta": null
  }
}